Real-time enrollment status for this drug:nanoliposomal irinotecan clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 5:35 PM UTC
| NCT Number | NCT06835387 |
| Recruiting Status | Recruiting |
| Condition | DRUG:Nanoliposomal irinotecan |
| Phase | PHASE2 |
| Target Enrollment | 36 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Tiago Biachi de Castria |
| Last Updated on CT.gov | June 25, 2026 (3 weeks ago) |
As of July 17, 2026: Clinical trial NCT06835387 is currently recruiting participants. This phase2 study for drug:nanoliposomal irinotecan is actively seeking new participants at 7 locations across the United States. The study is sponsored by Tiago Biachi de Castria. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06835387 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06835387 was last updated 3 weeks ago (June 25, 2026). HelloStudys verifies this status automatically.